Eaton Vance Management Blueprint Medicines Corp Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Eaton Vance Management holds 51,484 shares of BPMC stock, worth $4.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,484

Previous 51,610 0.24%

Holding current value

$4.47 Million

Previous $2.61 Million 30.11%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $6,291 - $9,790	-126 Reduced 0.24%	51,484 $3.39 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $2.45 Million - $3.8 Million	-54,219 Reduced 51.23%	51,610 $2.61 Million
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $8.51 Million - $17.3 Million	-157,356 Reduced 59.79%	105,829 $6.76 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $26,107 - $32,129	-277 Reduced 0.11%	263,185 $28.2 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $52,879 - $71,483	653 Added 0.25%	263,462 $27.1 Million
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $1.78 Million - $2.18 Million	-21,543 Reduced 7.58%	262,809 $23.1 Million
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $16.9 Million - $20.2 Million	-186,138 Reduced 39.56%	284,352 $27.6 Million
Q4 2020 Feb 12, 2021	BUY	$92.08 - $124.48 $19.8 Million - $26.8 Million	215,490 Added 84.51%	470,490 $52.8 Million
Q3 2020 Nov 13, 2020	SELL	$66.45 - $92.7 $17.7 Million - $24.7 Million	-266,403 Reduced 51.09%	255,000 $23.6 Million
Q2 2020 Nov 20, 2020	BUY	$57.09 - $79.27 $3,596 - $4,994	63 Added 0.01%	521,403 $40.7 Million
Q2 2020 Aug 13, 2020	BUY	$57.09 - $79.27 $516,264 - $716,838	9,043 Added 1.77%	521,340 $40.7 Million
Q1 2020 May 14, 2020	BUY	$48.11 - $82.22 $14.3 Million - $24.4 Million	296,931 Added 137.87%	512,297 $30 Million
Q4 2019 Feb 11, 2020	BUY	$66.73 - $82.59 $2.74 Million - $3.39 Million	41,016 Added 23.53%	215,366 $17.3 Million
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $5.97 Million - $8.3 Million	81,894 Added 88.58%	174,350 $12.8 Million
Q2 2019 Nov 21, 2019	BUY	$73.54 - $97.8 $8,824 - $11,736	120 Added 0.13%	92,456 $8.72 Million
Q2 2019 Aug 16, 2019	BUY	$73.54 - $97.8 $6.79 Million - $9.03 Million	92,336 New	92,336 $8.71 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.18B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Blueprint Medicines Corp Transaction History